Literature DB >> 17075653

Topical treatments for melasma and postinflammatory hyperpigmentation.

C B Lynde1, J N Kraft, C W Lynde.   

Abstract

Hyperpigmentation disorders of the skin are common and can be the source of significant psychosocial distress for patients. The most common of these disorders are melasma and postinflammatory hyperpigmentation. Sunscreen use and minimizing sun exposure are crucial in all cases. Topical applications are the mainstay of treatment and include phenols, retinoids, corticosteroids, and their combinations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075653

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  15 in total

Review 1.  [Fractional photothermolysis: a new option for treating melasma?].

Authors:  S Karsai; C Raulin
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

2.  [Fractional photothermolysis. Treatment of post-inflammatory hyperpigmentation following meadow grass dermatitis].

Authors:  L Schmitt; C Raulin; S Karsai
Journal:  Hautarzt       Date:  2009-07       Impact factor: 0.751

Review 3.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.

Authors:  Mark Nestor; Vivian Bucay; Valerie Callender; Joel L Cohen; Neil Sadick; Heidi Waldorf
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

4.  Nanoparticle-in-gel system for delivery of vitamin C for topical application.

Authors:  Sanjukta Duarah; Ramya Devi Durai; VedhaHari B Narayanan
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

5.  Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex.

Authors:  Li-Ning Huang; Yi-Ping Zhong; Dan Liu; Xiao-Hua Wang; Can-Yi Gong; Si Wen; Peter M Elias; Bin Yang; Mao-Qiang Man
Journal:  Contact Dermatitis       Date:  2018-09-12       Impact factor: 6.600

6.  Evidence-based treatment for melasma: expert opinion and a review.

Authors:  Krupa Shankar; Kiran Godse; Sanjeev Aurangabadkar; Koushik Lahiri; Venkat Mysore; Anil Ganjoo; Maya Vedamurty; Malavika Kohli; Jaishree Sharad; Ganesh Kadhe; Pashmina Ahirrao; Varsha Narayanan; Salman Abdulrehman Motlekar
Journal:  Dermatol Ther (Heidelb)       Date:  2014-10-01

7.  Crystal structure of 2-(4-acetyl-anilino)-2-oxoethyl 3-(4-hy-droxy-phen-yl)propionate.

Authors:  Zaman Ashraf; Daeyoung Kim; Sung-Yum Seo; Sung Kwon Kang
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-06-10

8.  Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.

Authors:  Qamar Abbas; Zaman Ashraf; Mubashir Hassan; Humaira Nadeem; Muhammad Latif; Samina Afzal; Sung-Yum Seo
Journal:  Drug Des Devel Ther       Date:  2017-07-05       Impact factor: 4.162

9.  Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.

Authors:  Zaman Ashraf; Muhammad Rafiq; Humaira Nadeem; Mubashir Hassan; Samina Afzal; Muhammad Waseem; Khurram Afzal; Jalifah Latip
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

10.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.